Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice

This publication has 31 references indexed in Scilit:

• Deletion of Deoxyribonucleic Acid Binding Domain of the Vitamin D Receptor Abrogates Genomic and Nongenomic Functions of Vitamin D
  Molecular Endocrinology, 2002
• Thiol protecting agents and antioxidants inhibit the mitochondrial permeability transition promoted by etoposide: implications in the prevention of etoposide-induced apoptosis
  Chemico-Biological Interactions, 2002
• SUM-159PT cells: a novel estrogen independent human breast cancer model system
  Breast Cancer Research and Treatment, 1999
• A phase I study of the vitamin D analogue EB 1089 in patients with advanced breast and colorectal cancer
  British Journal of Cancer, 1998
• Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene
  Carcinogenesis: Integrative Cancer Research, 1996
• EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro
  Biochemical Pharmacology, 1992
• 20-EPI-vitamin D3 analogues: A novel class of potent regulators of cell growth and immune responses
  Biochemical Pharmacology, 1991
• A Novel Vitamin D₃Analog, 22-Oxa-1, 25- Dihydroxyvitamin D₃, Inhibits the Growth of Human Breast Cancerin Vitroandin Vivowithout Causing Hypercalcemia*
  Endocrinology, 1991
• POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION
  The Lancet, 1989
• 1,25-Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20)
  Journal of Steroid Biochemistry, 1986